Recruiting
Phase 2

Immune Modulation by Abemaciclib in HNSCC. (AIM Trial)

Sponsor:

University of Arizona

Code:

NCT04169074

Conditions

HNSCC

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information